Detailed information for compound 1974067

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 394.268 | Formula: C16H12F6N2O3
  • H donors: 2 H acceptors: 2 LogP: 3.09 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1cc(ccc1OCCC(F)(F)F)C(F)(F)F)Nc1cc[nH]c(=O)c1
  • InChi: 1S/C16H12F6N2O3/c17-15(18,19)4-6-27-12-2-1-9(16(20,21)22)7-11(12)14(26)24-10-3-5-23-13(25)8-10/h1-3,5,7-8H,4,6H2,(H2,23,24,25,26)
  • InChiKey: BXOIJQLSRAKHJK-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Sodium channel protein type X alpha subunit Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Leishmania donovani calcium channel protein, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus multilocularis sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania major calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania braziliensis calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus granulosus voltage gated sodium channel Nav1 alpha subunit Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania mexicana calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus granulosus sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania infantum calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0202 0.271 0.5
Echinococcus granulosus thioredoxin glutathione reductase 0.0583 1 1
Loa Loa (eye worm) glutathione reductase 0.0583 1 0.5
Plasmodium falciparum glutathione reductase 0.0583 1 1
Brugia malayi Thioredoxin reductase 0.0583 1 1
Trypanosoma brucei trypanothione reductase 0.0583 1 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0202 0.271 0.5
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0202 0.271 0.1234
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0202 0.271 0.5
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0202 0.271 0.271
Giardia lamblia NADH oxidase lateral transfer candidate 0.0202 0.271 0.5
Trichomonas vaginalis mercuric reductase, putative 0.0202 0.271 0.5
Leishmania major 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein 0.0202 0.271 0.271
Loa Loa (eye worm) thioredoxin reductase 0.0583 1 0.5
Plasmodium vivax glutathione reductase, putative 0.0583 1 1
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0202 0.271 0.5
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0202 0.271 0.5
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0202 0.271 0.5
Toxoplasma gondii thioredoxin reductase 0.0583 1 1
Trichomonas vaginalis glutathione reductase, putative 0.0202 0.271 0.5
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0583 1 1
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0202 0.271 0.271
Plasmodium falciparum thioredoxin reductase 0.0583 1 1
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0202 0.271 0.271
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0202 0.271 0.271
Trypanosoma cruzi trypanothione reductase, putative 0.0583 1 1
Leishmania major trypanothione reductase 0.0583 1 1
Treponema pallidum NADH oxidase 0.0202 0.271 0.5
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0202 0.271 0.5
Echinococcus multilocularis thioredoxin glutathione reductase 0.0583 1 1
Leishmania major acetoin dehydrogenase e3 component-like protein 0.0202 0.271 0.271
Plasmodium vivax thioredoxin reductase, putative 0.0583 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 330 nM BindingDB_Patents: Electrophysiology Assay. Patch clamp electrophysiology was used to assess the efficacy and selectivity of sodium channel blockers in dorsal root ganglion neurons. Rat neurons were isolated from the dorsal root ganglions and maintained in culture for 2 to 10 days in the presence of NGF (50 ng/ml) (culture media consisted of NeurobasalA supplemented with B27, glutamine and antibiotics). Small diameter neurons (nociceptors, 8-12 ┬Ám in diameter) were visually identified and probed with fine tip glass electrodes connected to an amplifier (Axon Instruments). The voltage clamp mode was used to assess the compound's IC50 holding the cells at -60 mV. In addition, the current clamp mode was employed to test the efficacy of the compounds in blocking action potential generation in response to current injections. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.